Compare Nuwellis Inc (NUWE) vs PAGSEG Inc (PAGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs PAGSEG Inc — how do they compare? Nuwellis Inc trades at $0.68 (market cap $2.20M), while PAGSEG Inc trades at $11.16 (market cap $2.94B). The key difference: PAGSEG Inc is far larger — about 1336.4× Nuwellis Inc's market cap, and PAGSEG Inc pays a 10.49% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and PAGSEG Inc for 26 Days on average.
| NUWE | PAGS | |
|---|---|---|
Market Cap | $2.20M | $2.94B |
Volume | 121,544 | 4,242,708 |
Sector | Health | Industrials |
52-Week High | $146.65 | $12.00 |
52-Week Low | $0.68 | $8.44 |
Typical Hold Time | 26 Days | 26 Days |
Enterprise Value | -$1.52M | $11.02B |
Dividend Yield | — | 10.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
PAGS trades at $11.13, up 5.9% in the last 24 hours, with a bullish technical signal from moving averages. The stock shows strong fundamentals with a low P/E of 7.1 and robust profitability, including a 10.45% net income margin. Recent earnings beat expectations in Q2 2026, and the company maintains a solid dividend yield, supported by positive cash flow from operations of $7.56B in 2025.
The outlook for PAGS is positive, driven by undervaluation and earnings growth potential, but risks include macroeconomic pressures in Brazil and increased credit losses. Analyst consensus is strongly bullish with a $10.70 price target, though near-term volatility may persist due to mixed technical oscillators and competitive challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About PAGSEG Inc
PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →
